Jon Carl Serbousek's most recent trade in Orthofix Medical Inc was a trade of 6,141 Common Stock done at an average price of $16.8 . Disclosure was reported to the exchange on April 3, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.75 per share. | 03 Apr 2023 | 6,141 | 346,827 (1%) | 0% | 16.8 | 102,862 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.54 per share. | 01 Feb 2023 | 5,142 | 352,968 (1%) | 0% | 21.5 | 110,759 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 81,967 | 358,110 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 81,967 | 358,110 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,872 | 235,379 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,872 | 235,379 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 40,764 | 276,143 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 40,764 | 276,143 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.21 per share. | 01 Nov 2022 | 2,369 | 186,551 (0%) | 0% | 16.2 | 38,401 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.77 per share. | 05 Aug 2022 | 1,450 | 188,920 (0%) | 0% | 22.8 | 33,017 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 3,899 | 190,880 (0%) | 0% | 33.0 | 128,823 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 2,041 | 188,839 (0%) | 0% | 33.0 | 67,435 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 81,967 | 194,779 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 81,967 | 81,967 | - | - | Performance Share Units | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Purchase of securities on an exchange or from another person at price $ 31.14 per share. | 18 Nov 2021 | 1,670 | 112,812 (0%) | 0% | 31.1 | 52,004 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.87 per share. | 01 Nov 2021 | 2,369 | 109,903 (0%) | 0% | 36.9 | 87,345 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.98 per share. | 05 Aug 2021 | 1,450 | 112,272 (0%) | 0% | 38.0 | 55,071 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 40,764 | 116,506 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 40,764 | 40,764 | - | - | Performance Share Units | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 2,784 | 113,722 (0%) | 0% | 42.9 | 119,517 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.26 per share. | 01 Nov 2020 | 1,466 | 74,181 (0%) | 0% | 31.3 | 45,827 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.24 per share. | 07 Aug 2020 | 897 | 75,647 (0%) | 0% | 33.2 | 29,816 | Common Stock |